Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tacrolimus pharmacokinetics in BMT patients.
Boswell GW, Bekersky I, Fay J, Wingard J, Antin J, Weisdorf D, Maher R, Fitzsimmons W, Nash R. Boswell GW, et al. Among authors: antin j. Bone Marrow Transplant. 1998 Jan;21(1):23-8. doi: 10.1038/sj.bmt.1701054. Bone Marrow Transplant. 1998. PMID: 9486490 Clinical Trial.
Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease.
Walters MC, Eapen M, Liu Y, El Rassi F, Waller EK, Levine JE, Strouse JJ, Antin JH, Parikh SH, Bakshi N, Dampier CD, Jaroscak JJ, Bergmann S, Wong TE, Kota VK, Pace BS, Lekakis LJ, Lulla PD, Nickel R, Kasow KA, Popat UR, Smith WR, Yu LC, DiFronzo NL, Geller NL, Kamani N, Klings ES, Hassell K, Mendizabal AM, Sullivan K, Neuberg DS, Krishnamurti L. Walters MC, et al. Among authors: antin jh. Blood Adv. 2024 Oct 29:bloodadvances.2024013926. doi: 10.1182/bloodadvances.2024013926. Online ahead of print. Blood Adv. 2024. PMID: 39471440
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy.
Iftikhar R, DeFilipp Z, DeZern AE, Pulsipher MA, Bejanyan N, Burroughs LM, Kharfan-Dabaja MA, Arai S, Kassim A, Nakamura R, Saldaña BJD, Aljurf M, Hamadani M, Carpenter PA, Antin JH. Iftikhar R, et al. Among authors: antin jh. Transplant Cell Ther. 2024 Dec;30(12):1155-1170. doi: 10.1016/j.jtct.2024.09.017. Epub 2024 Sep 20. Transplant Cell Ther. 2024. PMID: 39307421 Free article.
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study.
Eapen M, Antin JH, Tolar J, Arai S, Horwitz ME, Kou J, Leifer E, McCarty JM, Nakamura R, Pulsipher MA, Rowley SD, Horowitz MM, Deeg HJ. Eapen M, et al. Among authors: antin jh. EClinicalMedicine. 2024 Sep 5;76:102819. doi: 10.1016/j.eclinm.2024.102819. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39290639 Free PMC article.
A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH): A Pilot Randomized Clinical Trial.
Amonoo HL, Daskalakis E, Wolfe ED, Guo M, Celano CM, Healy BC, Cutler CS, Antin JH, Pirl WF, Park ER, Jim HSL, Lee SJ, LeBlanc TW, El-Jawahri A, Huffman JC. Amonoo HL, et al. Among authors: antin jh. J Natl Compr Canc Netw. 2024 Jun;22(2 D):e237117. doi: 10.6004/jnccn.2023.7117. J Natl Compr Canc Netw. 2024. PMID: 38862012 Clinical Trial.
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival.
Shapiro RM, Kim HT, Dulery R, Liney D, Garrity HM, Panaro K, Au C, Gervais C, Little JS, Ho VT, Cutler CS, Koreth J, Gooptu M, Antin JH, Kelkar AH, Romee R, Wu CJ, Ritz J, Soiffer RJ, Nikiforow S. Shapiro RM, et al. Among authors: antin jh. Blood Adv. 2024 Sep 10;8(17):4729-4737. doi: 10.1182/bloodadvances.2023012418. Blood Adv. 2024. PMID: 38748871 Free PMC article.
544 results